Standout Papers

Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous s... 2016 2026 2019 2022 472
  1. Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study (2016)
    Jacqueline A. French, John A. Lawson et al. The Lancet
  2. Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial (2019)
    Lieven Lagae, Joseph Sullivan et al. The Lancet

Immediate Impact

1 from Science/Nature 57 standout
Sub-graph 1 of 20

Citing Papers

mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment
2024 Standout
AI revolutionizing industries worldwide: A comprehensive overview of its diverse applications
2024 Standout
1 intermediate paper

Works of Tilman Polster being referenced

Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study
2016 Standout
Detection of generalized tonic–clonic seizures by a wireless wrist accelerometer: A prospective, multicenter study
2013

Author Peers

Author Last Decade Papers Cites
Tilman Polster 1095 641 411 428 54 2.0k
Angus A. Wilfong 1249 622 367 665 67 2.6k
Raffaella Cusmai 1077 823 668 508 67 2.5k
Willem F. Arts 1024 874 207 319 45 1.9k
Angelika Mühlebner 768 469 496 384 58 1.7k
Eleanor Hancock 1475 1054 434 304 28 2.0k
Arielle Crespel 1412 743 173 843 100 2.4k
Gerhard Kurlemann 946 757 178 428 90 2.2k
Lucia Fusco 1477 713 127 579 83 2.1k
John Osborne 1649 1177 988 305 55 3.0k
Rainer Boor 1443 721 166 574 71 2.4k

All Works

Loading papers...

Rankless by CCL
2026